Ajax-Loading

Johnson & Johnson - Cash Flows Other Operating

Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Cash-Flows-Other-Operating" stands at 5.20 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 09/30/2013.

Johnson & Johnson's third quarter result of 2.22 Billion USD for the item "Cash Flows Other Operating" represents an increase of 168.85 percent compared to it's second quarter result.

Also, Johnson & Johnson's third quarter result of 2.22 Billion USD for the item "Cash Flows Other Operating" represents an increase of 2,364.44 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Johnson & Johnson's third quarter result of 5.20 Billion USD for the item "Cash Flows Other Operating" represents an increase of 69.29 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 9.78 Billion United States Dollars compared to the value the year prior.
The 1 year change is 9.78 Billion United States Dollars.
The 3 year change is 7.20 Billion United States Dollars.
The 5 year change is 5.79 Billion United States Dollars.
The 10 year change is 4.82 Billion United States Dollars.

The Serie's long term average value is -0.4 Billion United States Dollars. It's latest available value, on 09/30/2025, is 5.60 Billion United States Dollars higher, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 09/30/2024, to it's latest available value, on 09/30/2025, is +9.78 Billion.
The Serie's change in United States Dollars from it's maximum value, on 06/30/2013, to it's latest available value, on 09/30/2025, is -0.824 Billion.

Cash Flows Other Operating for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Cash Flows Other Operating905,699,262,464.00
LogoAbbVie Inc - Cash Flows Other Operating399,570,305,024.00
LogoRoche Holding AG - Cash Flows Other Operating317,433,206,677.55
LogoAstraZeneca PLC - Cash Flows Other Operating280,205,508,085.11
LogoNovartis AG - Cash Flows Other Operating255,096,620,580.91